Article
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
PloS one - 1 Jan 2014
Kuo Wen-Liang, Sharifi Marina N, Lingen Mark W, Ahmed Omar, Liu Jing, Nagilla Madhavi, Macleod Kay F, Cohen Ezra E W
Abstract excerpt
The phosphoinositol-3 kinase (PI3K) pathway is highly dysregulated in squamous cell carcinoma of the head and neck (SCCHN). While inhibitors of the PI3K/AKT pathway are being developed in cancer, their efficacy does not appear to be related to the presence of mutations or amplification in pathway genes. The PI3K pathway is a major regulator of macro-autophagy, an evolutionarily conserved catabolic process that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
